Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Silverman

Showing results (721-730 of 816) with videos related to

Pageof 82
Sort By:
Nature Communications|March 26, 2014
Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemiaBrenton G Mar, Lars B Bullinger, Kathleen M McLean, et al.
Blood|February 4, 2010
Inactivation of LEF1 in T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Takaomi Sanda, Wenxue Ma, et al.
Leukemia|March 4, 2005
No prognostic effect of additional chromosomal abnormalities in children with acute lymphoblastic leukemia and 11q23 abnormalitiesA V Moorman, S C Raimondi, C H Pui, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|June 20, 2016
Dietary intake and childhood leukemia: The Diet and Acute Lymphoblastic Leukemia Treatment (DALLT) cohort studyElena J Ladas, Manuela Orjuela, Kristen Stevenson, et al.
Journal of Medicinal Chemistry|December 2, 2011
(1S, 3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a potent γ-aminobutyric acid aminotransferase inactivator for the treatment of cocaine addictionYue Pan, Madina R Gerasimov, Trine Kvist, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2016
A Phase I Study of Quizartinib Combined with Chemotherapy in Relapsed Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) StudyTodd M Cooper, Jeannette Cassar, Elena Eckroth, et al.
Clinical Nutrition (Edinburgh, Scotland)|January 15, 2019
Fluctuations in dietary intake during treatment for childhood leukemia: A report from the DALLT cohortElena J Ladas, Manuela Orjuela, Kristen Stevenson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2008
Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxaneElly V Barry, Lynda M Vrooman, Suzanne E Dahlberg, et al.
Blood|October 5, 2011
Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemiaNobuko Hijiya, Blythe Thomson, Michael S Isakoff, et al.
Journal of the National Cancer Institute|June 1, 2023
Disparities in parental distress in a multicenter clinical trial for pediatric acute lymphoblastic leukemiaPuja J Umaretiya, Victoria B Koch, Yael Flamand, et al.
Pageof 82

Showing results (721-730 of 816) with videos related to

Sort By:
Pageof 82
Nature Communications|March 26, 2014
Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemiaBrenton G Mar, Lars B Bullinger, Kathleen M McLean, et al.
Blood|February 4, 2010
Inactivation of LEF1 in T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Takaomi Sanda, Wenxue Ma, et al.
Leukemia|March 4, 2005
No prognostic effect of additional chromosomal abnormalities in children with acute lymphoblastic leukemia and 11q23 abnormalitiesA V Moorman, S C Raimondi, C H Pui, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|June 20, 2016
Dietary intake and childhood leukemia: The Diet and Acute Lymphoblastic Leukemia Treatment (DALLT) cohort studyElena J Ladas, Manuela Orjuela, Kristen Stevenson, et al.
Journal of Medicinal Chemistry|December 2, 2011
(1S, 3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a potent γ-aminobutyric acid aminotransferase inactivator for the treatment of cocaine addictionYue Pan, Madina R Gerasimov, Trine Kvist, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2016
A Phase I Study of Quizartinib Combined with Chemotherapy in Relapsed Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) StudyTodd M Cooper, Jeannette Cassar, Elena Eckroth, et al.
Clinical Nutrition (Edinburgh, Scotland)|January 15, 2019
Fluctuations in dietary intake during treatment for childhood leukemia: A report from the DALLT cohortElena J Ladas, Manuela Orjuela, Kristen Stevenson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2008
Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxaneElly V Barry, Lynda M Vrooman, Suzanne E Dahlberg, et al.
Blood|October 5, 2011
Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemiaNobuko Hijiya, Blythe Thomson, Michael S Isakoff, et al.
Journal of the National Cancer Institute|June 1, 2023
Disparities in parental distress in a multicenter clinical trial for pediatric acute lymphoblastic leukemiaPuja J Umaretiya, Victoria B Koch, Yael Flamand, et al.
Pageof 82